Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Haritaki churna is a traditional Ayurvedic herbal formulation consisting of the powdered fruit of *Terminalia chebula*. It is traditionally used for gastrointestinal health and as a rejuvenative (Rasayana) tonic. Modern pharmacological studies indicate that its aqueous extract (HCAE) possesses significant anti-cancer activity, particularly against colorectal and esophageal cancer cells. Its mechanism involves the action of bioactive polyphenols like ellagic acid and chebulinic acid, which induce S-phase cell cycle arrest and mitochondrial apoptosis. Network pharmacology has identified several protein targets, including c-Src kinase, EGFR, and Akt1, which are downregulated by the formulation. It is also used as an adjuvant therapy in conditions like trigger finger due to its anti-inflammatory and strengthening properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on haritaki churna.